• 1
    Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G. J., Card, D., Keohane, C. et al., Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002. 296: 346349.
  • 2
    Brinkmann, V. and Lynch, K. R., FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr. Opin. Immunol. 2002. 14: 569575.
  • 3
    Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand et al., The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 2002. 277: 2145321457.
  • 4
    Brinkmann, V., Pinschewer, D. D., Feng, L. and Chen, S., FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 2001. 72: 764769.
  • 5
    Dragun, D., Bohler, T., Nieminen-Kelha, M., Waiser, J., Schneider, W., Haller, H., Luft, F. C., Budde, K. and Neumayer, H. H., FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int. 2004. 65: 10761083.
  • 6
    Budde, K., Schmouder, R. L., Brunkhorst, R., Nashan, B., Lucker, P. W., Mayer, T., Choudhury, S., Skerjanec, A., Kraus, G. and Neumayer, H. H., First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J. Am. Soc. Nephrol. 2002. 13: 10731083.
  • 7
    Kahan, B. D., Karlix, J. L., Ferguson, R. M., Leichtman, A. B., Mulgaonkar, S., Gonwa, T. A., Skerjanec, A., Schmouder, R. L. and Chodoff, L., Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Transplantation 2003. 76: 10791084.
  • 8
    Rosen, H. and Liao, J., Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm. Curr. Opin. Chem. Biol. 2003. 7: 461468.
  • 9
    Goetzl, E. J. and An, S., Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 1998. 12: 15891598.
  • 10
    Olivera, A., Rosenfeldt, H. M., Bektas, M., Wang, F., Ishii, I., Chun, J., Milstien, S. and Spiegel, S., Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J. Biol. Chem. 2003. 278: 4645246460.
  • 11
    Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L. and Cyster, J. G., Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004. 427: 355360.
  • 12
    Graler, M. H. and Goetzl, E. J., The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 2004. 18: 551553.
  • 13
    Sanchez, T., Estrada-Hernandez, T., Paik, J. H., Wu, M. T., Venkataraman, K., Brinkmann, V., Claffey, K. and Hla, T., Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 2003. 278: 4728147290.
  • 14
    Kluk, M. J. and Hla, T., Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta 2002. 1582: 7280.
  • 15
    Takuwa, Y., Takuwa, N. and Sugimoto, N., The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. J. Biochem. (Tokyo) 2002. 131: 767771.
  • 16
    Siehler, S. and Manning, D. R., Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. Biochim. Biophys. Acta 2002. 1582: 9499.
  • 17
    Goetzl, E. J., Kong, Y. and Voice, J. K., Cutting edge: Differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. J. Immunol. 2000. 164: 49964999.
  • 18
    Idzko, M., Panther, E., Corinti, S., Morelli, A., Ferrari, D., Herouy, Y., Dichmann, S., Mockenhaupt, M., Gebicke-Haerter, P., Di Virgilio, F., Girolomoni, G. and Norgauer, J., Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 2002. 16: 625627.
  • 19
    Morelli, A. E. and Thomson, A. W., Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 2003. 196: 125146.
  • 20
    Morelli, A. E., Hackstein, H. and Thomson, A. W., Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 2001. 13: 323335.
  • 21
    Zhang, M., Wang, Q., Liu, Y., Sun, Y., Ding, G., Fu, Z., Min, Z., Zhu, Y. and Cao, X., Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival. J. Mol. Med. 2004. 82: 240249.
  • 22
    Hackstein, H. and Thomson, A. W., Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004. 4: 2434.
  • 23
    Dunzendorfer, S., Kaser, A., Meierhofer, C., Tilg, H. and Wiedermann, C. J., Cutting edge: Peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J. Immunol. 2001. 166: 21672172.
  • 24
    Dorsam, G., Graeler, M. H., Seroogy, C., Kong, Y., Voice, J. K. and Goetzl, E. J., Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J. Immunol. 2003. 171: 35003507.
  • 25
    Cummings, R. J., Parinandi, N. L., Zaiman, A., Wang, L., Usatyuk, P. V., Garcia, J. G. and Natarajan, V., Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells. J. Biol. Chem. 2002. 277: 3022730235.
  • 26
    Ammit, A. J., Hastie, A. T., Edsall, L. C., Hoffman, R. K., Amrani, Y., Krymskaya, V. P., Kane, S. A., Peters, S. P., Penn, R. B., Spiegel, S. and Panettieri, R. A., Jr., Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001. 15: 12121214.
  • 27
    Randolph, G. J., Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 2001. 13: 267274.
  • 28
    Randolph, G. J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R. M. and Muller, W. A., A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. USA 1998. 95: 69246929.
  • 29
    Robbiani, D. F., Finch, R. A., Jager, D., Muller, W. A., Sartorelli, A. C. and Randolph, G. J., The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000. 103: 757768.
  • 30
    Weninger, W. and von Andrian, U. H., Chemokine regulation of naive T cell traffic in health and disease. Semin. Immunol. 2003. 15: 257270.
  • 31
    Graeler, M., Shankar, G. and Goetzl, E. J., Cutting edge: Suppression of T cell chemotaxis by sphingosine 1-phosphate. J. Immunol. 2002. 169: 40844087.
  • 32
    Fiorini, M., Vermi, W., Facchetti, F., Moratto, D., Alessandri, G., Notarangelo, L., Caruso, A., Grigolato, P., Ugazio, A. G., Notarangelo, L. D. and Badolato, R., Defective migration of monocyte-derived dendritic cells in LAD-1 immunodeficiency. J. Leukoc. Biol. 2002. 72: 650656.
  • 33
    Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D. and Schuler, G., Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 1996. 196: 137151.
  • 34
    Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J. and Enk, A. H., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997. 27: 31353142.
  • 35
    Dunzendorfer, S., Kaser, A., Meierhofer, C., Tilg, H. and Wiedermann, C. J., Dendritic cell migration in different micropore filter assays. Immunol. Lett. 2000. 71: 511.
  • 36
    Kaser, A., Kaser, S., Kaneider, N. C., Enrich, B., Wiedermann, C. J. and Tilg, H., Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood 2004. 103: 648655.
  • 37
    Romani, N., Bhardwaj, N., and Pope, M., Dendritic cells. In Herzenberg, L. A., Weir, D. M., Herzenberg, L. and Blackwell, C. (Eds.) Weir's Handbook of Experimental Immunology. Blackwell Science, Oxford 1997, pp 156.1156.14.
  • 38
    Ebner, S., Hofer, S., Nguyen, V. A., Furhapter, C., Herold, M., Fritsch, P., Heufler, C. and Romani, N., A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J. Immunol. 2002. 168: 61996207.
  • 39
    Graf, D., Korthauer, U., Mages, H. W., Senger, G. and Kroczek, R. A., Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 1992. 22: 31913194.